On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer ...

Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

Pfizer is looking to sell about 700 million ordinary shares in Haleon, its bookrunner J.P. Morgan said on Tuesday, lowering ...

Marcum Wealth LLC raised its holdings in shares of Haleon plc (NYSE:HLN – Free Report) by 19.7% in the fourth quarter, ...

Pfizer divests $3.05 billion of Haleon shares, cutting its stake to 7.3% in a strategic shift to refocus on core ...

Pfizer ( NYSE: PFE) announced Tuesday it plans to sell roughly 700M ordinary shares in Haleon ( NYSE: HLN) to lower its stake ...

Pfizer (PFE) announces that it intends to sell approximately 700M ordinary shares in Haleon plc (HLN), representing approximately 7.7% of ...

Morgan Stanley downgraded shares of Haleon (NYSE:HLN – Free Report) from an overweight rating to an equal weight rating in a ...

Wednesday announced the sale of 700 million shares in Haleon Plc (HLN), a British multinational consumer healthcare ...

In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...